In case you missed it in @ACR_Journals: HCQ for 1y does not prevent RA development in people with CCP3 >2x ULN, either:
- during 1y of treatment
- in 2y follow-up
https://t.co/gtzNiSmutb
but StopRA will give us plenty of insights - data is never wasted
#ACR25 ABST1674 @RheumNow https://t.co/DDZib5VGtX
Links:
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid art…
https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.43366
27-10-2025
